The Board of Directors of Guangzhou Wondfo Biotech Co.,Ltd has authorized a buyback plan on July 5, 2023.
Guangzhou Wondfo Biotech Co.,Ltd
Equities
300482
CNE100002102
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
29.66 CNY | +2.49% | -1.23% | -1.69% |
06/05 | Wondfo Biotech's Unit Gets Emergency Use Authorization from US FDA | MT |
21/04 | Guangzhou Wondfo Biotech Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-1.69% | 187.43Cr | |
-1.52% | 836.95Cr | |
+10.68% | 583.76Cr | |
+26.94% | 539.81Cr | |
-5.09% | 436.65Cr | |
-52.54% | 322.85Cr | |
+14.18% | 279.52Cr | |
+32.50% | 225.64Cr | |
-6.47% | 221.61Cr | |
+3.89% | 159.71Cr |
- Stock Market
- Equities
- 300482 Stock
- News Guangzhou Wondfo Biotech Co.,Ltd
- Guangzhou Wondfo Biotech Co.,Ltd authorizes a Buyback Plan.